Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login
Market Place

Information, Expiry & Status of Health Canada Patents covering AM20070676.

Client Email

Product

AM20070676
HEALTH CANADA PATENTS

PharmaCompass Sponsored Ads

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

PharmaCompass Sponsored Ads

Contact Supplier

AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

AM20070676

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

102 API Suppliers, 46 USDMF, 41 CEP/COS, 10 JDMF, 32 EU WC, 41 KDMF, 31 NDC API, 59 Listed Suppliers, $ API Reference Price

102 API Suppliers
46 USDMF
41 CEP/COS
10 JDMF
32 EU WC
41 KDMF
31 NDC API
59 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

12 Drugs in Development

12 Drugs in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Exports, FDF Imports

API Reference Price
API Exports
API Imports
FDF Exports
FDF Imports

INTERMEDIATES

22 API Suppliers

22 API Suppliers

FINISHED DOSAGE FORMULATIONS

1031 FDF Dossiers, 241 FDA Orange Book, 503 Europe, 61 Canada, 68 Australia, 26 South Africa, 132 Listed Dossiers

1031 FDF Dossiers
241 FDA Orange Book
503 Europe
61 Canada
68 Australia
26 South Africa
132 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 1GM, TABLET;ORAL - 250MG, TABLET;ORAL - 500MG, TABLET;ORAL - 750MG, INJECTABLE;INTRAVENOUS - 500MG/5ML (100MG/ML), TABLET, EXTENDED RELEASE;ORAL - 500MG, TABLET, EXTENDED RELEASE;ORAL - 750MG

TABLET;ORAL - 1GM
TABLET;ORAL - 250MG
TABLET;ORAL - 500MG
TABLET;ORAL - 750MG
INJECTABLE;INTRAVENOUS - 500MG/5ML (100MG/ML)
TABLET, EXTENDED RELEASE;ORAL - 500MG
TABLET, EXTENDED RELEASE;ORAL - 750MG

RELATED EXCIPIENT COMPANIES

1 Evonik, 7 Rochem International Inc, 18 SPI Pharma, 2 Seqens, 7 DKSH, 2 Jai Radhe Sales, 2 Pharm-RX Chemical, 12 Boai NKY Pharmaceuticals Ltd, 16 Gangwal Healthcare, 13 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 1 ACG Worldwide, 15 Actylis, 2 Aeon Procare, 3 Alcedo Pharmachem, 10 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Avesta Pharma, 42 BASF, 1 Bioplus Life Sciences, 2 Clariant, 14 Corel Pharma Chem, 7 DFE Pharma, 2 Finar, 13 Gangwal Chemicals, 1 Huzhou Sunflower Pharmaceutical, 7 Ideal Cures Pvt Ltd, 5 Ingredion Pharma Solutions, 39 Kerry, 4 Kima Chemical, 6 Lonza Capsugel, 18 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nomisma Healthcare, 5 Novo Excipients, 4 Pharmatrans-Sanaq, 10 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 41 Roquette, 17 Seppic, 7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 12 Sigachi Industries, 3 The Dow Chemical Company, 4 Ulanqab Kema New Material, 2 Valens Pharmachem, 4 Vasa Pharmachem, 2 Vertellus, 2 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

120 Fillers, Diluents & Binders, 65 Coating Systems & Additives, 56 Direct Compression, 45 Thickeners and Stabilizers, 43 Disintegrants & Superdisintegrants, 43 Controlled & Modified Release, 40 Solubilizers, 39 Film Formers & Plasticizers, 39 Taste Masking, 38 Granulation, 34 Topical, 32 Parenteral, 27 Lubricants & Glidants, 22 Co-Processed Excipients, 20 Chewable & Orodispersible Aids, 16 Emulsifying Agents, 9 Surfactant & Foaming Agents, 9 API Stability Enhancers, 7 Rheology Modifiers, 5 Empty Capsules, 5 Coloring Agents, 4 Vegetarian Capsules, 1 Soft Gelatin

120 Fillers, Diluents & Binders
65 Coating Systems & Additives
56 Direct Compression
45 Thickeners and Stabilizers
43 Disintegrants & Superdisintegrants
43 Controlled & Modified Release
40 Solubilizers
39 Film Formers & Plasticizers
39 Taste Masking
38 Granulation
34 Topical
32 Parenteral
27 Lubricants & Glidants
22 Co-Processed Excipients
20 Chewable & Orodispersible Aids
16 Emulsifying Agents
9 Surfactant & Foaming Agents
9 API Stability Enhancers
7 Rheology Modifiers
5 Empty Capsules
5 Coloring Agents
4 Vegetarian Capsules
1 Soft Gelatin

DIGITAL CONTENT

6 DATA COMPILATION #PharmaFlow, 58 NEWS #PharmaBuzz

6 DATA COMPILATION #PharmaFlow
58 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

3 US Medicaid Prescriptions, 410 Finished Drug Prices, 11 Annual Reports

3 US Medicaid Prescriptions
410 Finished Drug Prices
11 Annual Reports

MARKET PLACE

34 APIs, 13 FDF Dossiers

34 APIs
13 FDF Dossiers

PATENTS & EXCLUSIVITIES

40 US Patents, 3 Health Canada Patents

40 US Patents
3 Health Canada Patents

REF. STANDARDS & IMPURITIES

5 EDQM, 4 USP, 9 Others

5 EDQM
4 USP
9 Others

ANALYTICAL

2 BioAnalytical Methods

2 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 65 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

3 All

01 3Gowling Lafleur Henderson LLP

filter Patent Reset all filters

3 All

01 32581831

filter Product Reset all filters

3 All

01 3LEVETIRACETAM

filter Dosage Reset all filters

3 All

01 3TABLET

filter Exp Date Reset all filters

3 All

01 32026-07-24

DRL Levetiracetam

US Patents
Health Canada Patents

Product Main Page

01

Gowling Lafleur Henderson LLP

Levetiracetam

AAPS 2024

Not Confirmed

Gowling Lafleur Henderson LLP

Canada

AAPS 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-07-24

Date Granted : 2013-11-12

Levetiracetam

Brand Name : KEPPRA

Patent Number : 2581831

Filing Date : 2006-07-24

Strength per Unit : 250 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2026-07-24

Date Granted : 2013-11-12

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Gowling Lafleur Henderson LLP

Levetiracetam

AAPS 2024

Not Confirmed

Gowling Lafleur Henderson LLP

Canada

AAPS 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-07-24

Date Granted : 2013-11-12

Levetiracetam

Brand Name : KEPPRA

Patent Number : 2581831

Filing Date : 2006-07-24

Strength per Unit : 500 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2026-07-24

Date Granted : 2013-11-12

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

Gowling Lafleur Henderson LLP

Levetiracetam

AAPS 2024

Not Confirmed

Gowling Lafleur Henderson LLP

Canada

AAPS 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-07-24

Date Granted : 2013-11-12

Levetiracetam

Brand Name : KEPPRA

Patent Number : 2581831

Filing Date : 2006-07-24

Strength per Unit : 750 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2026-07-24

Date Granted : 2013-11-12

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?